Key takeaways
- Clearing ethanol consumes NAD+ and generates a reactive aldehyde — one upstream event that explains most of the marker changes below it.
- Lower testosterone, higher effective estradiol, raised GGT, higher triglycerides and ApoB, raised blood pressure and inflammation all follow from it.
- The breast cancer association in women is linear from zero, with no threshold below which it disappears.
- Cutting back changes sleep within a week, liver enzymes within two months and hormones within three.
Alcohol is the variable people are most reluctant to examine and the one that most reliably explains a confusing panel. It is also unusual in that almost everything it does downstream comes from a single upstream event: how the liver disposes of ethanol. Understand that one reaction and this stops being a list of unrelated harms and becomes one mechanism showing up in nine places.
The one reaction that explains most of the list
Ethanol is metabolised in two steps. Alcohol dehydrogenase converts it to acetaldehyde, a reactive and directly toxic compound; aldehyde dehydrogenase then converts acetaldehyde to acetate, which is harmless. Both steps consume NAD+ and generate NADH.
That last detail is the important one. NAD+ is the cofactor the cell uses to run oxidative reactions, and while alcohol is being cleared the ratio of NADH to NAD+ inside the hepatocyte shifts sharply. In that state the liver cannot oxidise fatty acids at the normal rate, so fat accumulates and is exported as triglyceride-rich particles; gluconeogenesis is suppressed; and steroid metabolism, which is NAD-dependent, slows. Alcohol imposes a redox load plus a dose of a reactive aldehyde, and everything below follows from those two things and the disrupted sleep that accompanies them.
Testosterone in men
Acute alcohol intake suppresses testosterone within hours, measurable after a single evening (Smith et al., Expert Rev Endocrinol Metab 2023). Chronic intake above roughly seven drinks a week is associated with testosterone 5-15% lower in observational work.
The mechanism is layered, which is why it is hard to escape. Leydig cell steroidogenesis depends on NAD-linked steps, which the redox shift interferes with directly. Acetaldehyde is independently toxic to testicular tissue. LH signalling is blunted, aromatase activity rises, and disrupted sleep suppresses the overnight testosterone rise that produces most of a man's daily output. That is five hits at once, not one. Alcohol on testosterone therapy covers men already treated.
Estradiol
Estradiol is cleared by the liver, and its oxidative metabolism is NAD-dependent — so the same redox shift slows estradiol clearance, and effective estradiol rises without any change in production. In men this contributes to the high-estradiol picture and compounds the testosterone suppression from the other end. In perimenopausal women it worsens exactly the symptoms that were already the problem: heavier bleeding, breast tenderness, worse sleep. It is a frequent and unexamined contributor to heavier periods in your forties.
Sleep architecture
Alcohol is a sedative, and people reasonably conclude from feeling drowsy that it helps them sleep. What it does is enforce sedation in the first half of the night through GABA-A agonism while suppressing REM, then produce a rebound as it clears: sympathetic activation, raised heart rate, lighter sleep, early waking. Time in bed is unchanged; the architecture inside it is not, and wearables make that legible — overnight heart rate up, variability down, REM cut, from amounts most people consider trivial. Since sleep sits upstream of testosterone, cortisol, appetite and glucose handling, this is arguably the largest single channel through which alcohol moves the rest of a panel (sleep architecture and hormones).
Liver enzymes
ALT, AST and GGT all rise with chronic intake. GGT is the most sensitive to alcohol specifically, and rises well before clinical liver disease is apparent (Whitfield, Crit Rev Clin Lab Sci 2001). AST rising disproportionately to ALT is the classic alcohol pattern, and reflects mitochondrial injury rather than the hepatocellular pattern of metabolic fatty liver. These are also the fastest markers to reward a change — usually normalising within four to eight weeks, which makes GGT an unusually honest feedback loop (more on GGT).
Blood pressure
Alcohol raises blood pressure acutely through sympathetic activation, and chronic intake raises the baseline through sustained sympathetic tone, altered renin-angiotensin activity and impaired endothelial function. Each daily drink is associated with roughly 1 mmHg higher systolic pressure on average (Roerecke et al., Lancet Public Health 2017). Small-sounding, but linear, proportional to intake and reversible — one of the few blood pressure problems solved without a prescription.
Lipids and ApoB
Triglycerides rise, sometimes dramatically, for the redox reason above: a liver that cannot oxidise fat exports it. ApoB rises modestly with regular intake. HDL does rise slightly with moderate consumption, which was the original basis for believing drinking protects the heart — but raising HDL-C is not the same as reducing risk, and the net lipid effect here is unfavourable. The ApoB story explains why particle count is the number that matters.
Inflammation markers
hs-CRP and IL-6 rise with chronic intake by a route worth knowing. Alcohol increases intestinal permeability, allowing bacterial endotoxin into the portal circulation, where it activates hepatic Kupffer cells and drives IL-6 release; CRP follows. This is why the inflammatory signal can appear while liver enzymes are still normal — the gut-liver axis is affected before the hepatocytes are. Reduction lowers both within weeks.
Breast cancer in women
The dose-response is linear from zero, with no threshold below which the association disappears. The Million Women Study found each daily drink associated with roughly a 12% relative increase in risk (Allen et al., J Natl Cancer Inst 2009). Two mechanisms fit: acetaldehyde is genotoxic, and impaired hepatic clearance raises circulating estradiol, a growth signal for hormone-receptor-positive tissue. For a woman with family history or a prior diagnosis, this deserves an individual conversation rather than a rule of thumb.
What happened to the J-curve
The old picture — light drinkers doing better than abstainers — has weakened considerably, for two reasons. The abstainer group in older studies included people who had stopped because they were already unwell, which makes non-drinkers look worse than they are. And genetic analyses, immune to that confounding because the relevant variants are allocated at conception, do not reproduce the protective effect. Large pooled analyses now place the threshold for lowest harm well below previous guidance (Wood et al., Lancet 2018). The defensible statement is that less is better and no threshold has been shown below which alcohol is neutral — not that nobody should drink, but that the trade is real and should be made knowingly.
What changes when you cut back, and when
The order is consistent enough to plan around. Sleep quality changes first, usually within the first week. Blood pressure and inflammatory markers follow within a few weeks. Liver enzymes normalise over four to eight weeks. Testosterone, triglycerides and the estradiol picture land in the eight-to-twelve-week window.
Which means a two-week experiment is long enough to notice the sleep change and far too short to see the panel change. Draw a baseline, change one thing, re-draw at twelve weeks. For anyone actively optimising, fewer than three drinks a week — concentrated into occasions rather than spread across evenings — is the practical target, because the nightly pattern is the one that never lets the liver or the sleep recover. The 60-second assessment is the fastest route to that baseline panel.
The clinical pearl: low testosterone in a man, a raised GGT, high triglycerides or rising ApoB — or heavy periods and poor sleep in a woman in her forties — all warrant quantifying alcohol honestly before anything is prescribed. It is the highest-leverage variable on most panels and the one most often left out of the history.
Bottom line
Clearing ethanol shifts the liver's redox state and generates a reactive aldehyde. That one event explains lower testosterone, higher estradiol, higher triglycerides and ApoB, raised liver enzymes and blood pressure, higher inflammatory markers and the linear breast cancer association — with disrupted sleep amplifying all of it. The dose-response runs from zero with no demonstrated safe threshold. Cutting back changes sleep within a week, enzymes within two months and hormones within three: the most markers moved for the least effort, and the intervention most people would rather discuss last.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
